← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Dev. Op. Officer Tanya Lewis sold $220K of Replimune Group, Inc.

Sold$220,336
$18.05Price
12,207Shares
−8%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, May 16. Filed Thu, May 18, 4:34 PM ET, after the close. Not investment advice.